ARCHIVES

Blinatumomab Demonstrates High Response Rate in ALL

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

May 28, 2004

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

April 24, 1998

Michigan’s Zhang Wins “Protein Science Olympics”

January 14, 2011

No Proof Fiber Is Anticarcinogenic, Newell Says, But diet should Include Anyway

May 18, 1979

Marc Lippman To Leave Georgetown For Michigan To Head Internal Medicine; Five Named To DCLG.

September 15, 2000

More Bad News For Estrogen: Increased Ovarian Cancer Risk

July 19, 2002